Please use this identifier to cite or link to this item:
http://ricaxcan.uaz.edu.mx/jspui/handle/20.500.11845/2615
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | 46461 | es_ES |
dc.contributor.other | https://orcid.org/0000-0001-6803-925X | - |
dc.contributor.other | https://orcid.org/0000-0002-2979-6159 | - |
dc.coverage.spatial | Global | es_ES |
dc.creator | Quirarte Báez, Sol María | - |
dc.creator | Zamora Perez, Ana Lourdes | - |
dc.creator | Reyes Estrada, Claudia Araceli | - |
dc.creator | Gutiérrez Hernández, Rosalinda | - |
dc.creator | Sosa Macías, Martha | - |
dc.creator | Galaviz Hernández, Carlos | - |
dc.creator | Guerrero Manriquez, Gloria Guillermina | - |
dc.creator | Lazaldo Ramos, Blanca Patricia | - |
dc.date.accessioned | 2021-06-18T17:17:56Z | - |
dc.date.available | 2021-06-18T17:17:56Z | - |
dc.date.issued | 2019-12-03 | - |
dc.identifier | info:eu-repo/semantics/publishedVersion | es_ES |
dc.identifier.issn | 2561-8741 | es_ES |
dc.identifier.uri | http://ricaxcan.uaz.edu.mx/jspui/handle/20.500.11845/2615 | - |
dc.identifier.uri | https://doi.org/10.48779/vg31-3k15 | - |
dc.description.abstract | Background Rosemary leaves powder has been reported to reduce in a dose-dependent manner, glucose levels, lipid profile and lipid peroxidation in humans. However, patients should ingest high doses of powder contained in capsules. This formulation constitutes the intake of 10 capsules per day, so the active metabolite must first, be released and then absorbed (for which, rosemary leaf powder must be mixed with gastric juice). Aim Evaluate whether a shortened dose and time of treatment as well as the pharmaceutical presentation in rosemary tea (Rosmarinus officinalis) instead of powder have a therapeutic effect in the treatment of T2D. Method The complementary therapy with Rosemary tea (2g/1 litre of water per day) were evaluate on resistance to insulin, oxidative stress, biochemical parameters and anthropometric measurements in forty patients T2D under treatment with metformin and/or glibenclamide afther giving your authorization through informed consent. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Research Trentz | es_ES |
dc.relation | https://jptcp.com/index.php/jptcp/article/view/634 | es_ES |
dc.relation.ispartof | https://doi.org/10.15586/jptcp.v26i4.634 | es_ES |
dc.relation.uri | generalPublic | es_ES |
dc.rights | Atribución-NoComercial-CompartirIgual 3.0 Estados Unidos de América | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-sa/3.0/us/ | * |
dc.source | Journal of Population Therapeutics and Clinical Pharmacology, Vol. 26 No. 4 (2019) | es_ES |
dc.subject.classification | BIOLOGIA Y QUIMICA [2] | es_ES |
dc.subject.other | Rosemary | es_ES |
dc.subject.other | resistance to insulin | es_ES |
dc.subject.other | anthropometric parameters | es_ES |
dc.title | A shortened treatment with rosemary tea (rosmarinus officinalis) instead of glucose in patients with diabetes mellitus type 2 (TSD) | es_ES |
dc.type | info:eu-repo/semantics/article | es_ES |
Appears in Collections: | *Documentos Académicos*-- M. en Ciencias y Tecnología Química |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
A shortened treatment with rosemary tea (rosmarinus officinalis) instead of.pdf | 749,29 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License